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The  ligand-induced  internalization  of  @-adrenergic 
receptors  and  the  receptor-mediated  internalization  of 
epidermal  growth  factor were blocked,  under  similar 
conditions,  by  phenylarsine oxide (PAO) in human as- 
trocytoma cells (1321N1). The  inhibition  was not pre- 
vented  or  eversed  by  monofunctional  sulfhydryl 
agents  such as 2-mercaptoethanol  or  glutathione;  how- 
ever, the  inhibitory  action  of PA0 was  blocked  and 
reversed  by bifunction~ thiols  such as 2,3-dimercap- 
toethanol  or di~othreitol. The  results  are  consistent 
with  the  interaction of PA0 with  vicinal  sulfhydryl 
groups to form a  stabile  ring  structure. PA0 did  not 
prevent isoproterenol-induced uncoupling (desensiti- 
zation) of @-adrenergic  receptors even though  receptor 
internalization was completely  blocked.  The ffects of 
PA0 on receptor  internalization  could  not  be  explained 
by  any  action  of  the  trivalent  arsenical  to  lower ATP 
levels. Ligand binding to both  receptors was not  de- 
tectably  altered  by PA0 under  conditions selective for 
inhibition  for  endocytosis.  The  results  suggest  a  com- 
mon mechanism  for  internalization f @-adrenergic re- 
ceptors  and  epidermal  growth  factor  by  a  process  that 
involves  vicinal  sulfhydryl  groups. 
The activation by catecholamines of the @-adrenergic re- 
ceptor (BAR1)-linked adenylate cyclase is a transient effect 
in most cells.  Following  rapidly after the activation process, 
a set of temporally related events occur that lead to loss of 
response of the cell to catecholamines. As a part of this 
desensitization process,  a portion of the cell surface BAR was 
shown to change  form in a manner consistent with  receptor 
internalization (1-4). Thus, BAR can be isolated from  desen- 
sitized cells in a membrane form depleted of other plasma 
membrane marker proteins. Such receptors are poorly  acces- 
sible to hydrophilic ligands such as isoproterenol (3 )  and 
CGP-1217‘7 (4) ;  whereas, BAR on the surface of intact cells 
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or  in lysates from control cells are readily  accessible to these 
hydrophilic  ligands. These observations have  been i n t e ~ ~ ~ d  
as consistent with the proposal. that  the  ca~~ho~amine-in- 
duced form of BAR represents BAR with the ligand  binding 
site on the inside of endocytotic  vesicles. It follows that BAR 
might  be internalized and processed in a manner similar to 
receptor-mediated endocytosis of certain polypeptides (asi- 
aloglycoprotein, insulin, EGF, low density lipoprotein, etc; for 
review,  see  Ref. 5). Internalization of protein-receptor com- 
plexes appears to involve sequestration in clathrin-coated pits 
and internalization by endocytosis in vesicles  which simulta- 
neously can contain different protein-receptor complexes (6, 
7).  
The processing of polypeptide  ligand and receptor appears 
to vary. In some  cases the receptor  is  efficiently shuttled back 
to the cell surface 1) upon diisociation of the ligand and its 
degradation such as for asialoglycoprotein (8) and low density 
lipoprotein (9), or 2) with the protein ligand intact such as 
for transferrin (10). In some  cases both ligand and receptor 
are degraded (11). There is evidence that separation of a 
ligand destined for  degradation  (asialoglycoprotein) from the 
receptor destined to recycle to the cell surface occurs in 
tubular organelles termed “compartments of uncoupling of 
receptor and ligand” (8). 
In this report we compare the effects of the trivalent arsen- 
ical, phenylarsine oxide (PAO) on catecholamine-induced in- 
ternaIization of  BAR and receptor  mediated i n t e ~ a i i ~ t i o n  
of EGF in  the human astrocytoma cell line 1321N1. PA0 
previously had been shown to inhibit internalization of a 
variety of proteins (12-14) including EGF (15). We demon- 
strate that 1) PA0 inhibits the internalization of both BAR 
and EGF, 2) the effect of PA0 is reversed or prevented by 
bifunctional but not monofunctional  sulfplydryi agents, and 
3) the effect of PA0 cannot be explained on the basis of 
inhibition of energy  metabolism. 
E X ~ ~ I M E ~ T A L  PROCEDURES 
Muterials--(-)-Isoproterenol bitartrate, antimycin A, and 2-de- 
oxyglucose  were obtained from Sigma; epidermal growth factor from 
Biomedical Technologies, Cambridge, MA; ATP bioluminescence 
CLS kits from Boehringer Mannheim; phenylarsine oxide from Ald- 
rich. Phenylarsine oxide was dissolved in dimethyl sulfoxide and 
diluted to a final concentration of the solvent of 0.1%. The following 
drugs were gifts: (-)-Cyanopindolol from Sandoz, CGP-12177 from 
Dr. M. Staehelin, Basel.  1251-Cyanopindolol (CYP) was prepared by a 
modification of the method of Barovsky and Brooker (16). 12’I-EGF 
was prepared by the chloramine-T method (17). I3q]AT11 was syn- 
thesized as described (18). 
Cell Culture-Human astrocytoma cells (1321N1)  were maintained 
in Dulhecco’s modified  Eagle’s medium supplemented with 5% fetal 
calf serum. Growth of cells was carried out under an atmosphere of 
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92% air and 8% COZ at 37  "C in a humidified incubator. Cells were 
seeded at 1.5 X lo5 cells/cm2 and were subcultured 4 days prior to  the 
experiment. 
Binding of Cyanopindolol-To determine the  total number of BAR, 
lysates or membranes were incubated with 50 p~ (10 X KD) "I-CYP 
in 154 mM Nac1, 20  mM Tris, 5 mM &f&12, pH 7.4, in a total volume 
of 0.25 ml for 2  h at 30  "C. Nonspecific binding was determined in 
the presence of 1 pM propranoiol. 
intenalizution of BAR-Cells were incubated with 1 p~ (-)- 
isoproterenol for 20 min at 37  "C to induce receptor internalization. 
The internalized form of BAR was detected by two different methods. 
1) Sucrose density gradient centrifugation, in which desensitized cells 
were washed with Hepes-Eagle's medium incubated with 0.25 mg/ml 
concanavalin A  (19) for 20 min at 4 "C then lysed by hypotonic shock 
in 1 mM Tris, 2 mM EDTA, pH 7.4, for 20 min at 4 "C. Lysates were 
layered on top of a step gradient consisting of  3.2 ml of 15%, 4 ml of 
38%, and 4 ml of 60% sucrose (w/v in 20 mM Tris HCI, pH 7.4) and 
centrifuged for 30 min at 35,000 rpm in a Beckman SW 40 rotor. The 
interfaces were collected and diluted k1 with 154 mM NaCl, 20 mM 
Tris, 5 mM MgClz, pH 7.4, and BAR  was determined by binding of 
'25]1-CYP. Internalized BAR migrated preferentially at  the 15-38% 
interface and BAR on the plasma membrane at the 3840% interface. 
2) Competition binding, in which desensitized cells were  washed and 
lysed by hypotonic shock in 1 mM Tris, 2 mM EDTA, pH 7.4, for 20 
min at 4 "C. Competition binding was carried out with diluted lysates 
using 10 pM '251-CYP and a range of concentrations of CGP-12177 
(incubation was carried out at 30 'C for 2 h (20)). Internalized BAR 
(vesicles in the lysate) exhibited a marked inaccessibility to CGP- 
12177. The increase in '251-CYP binding in  the presence of 10 nM 
CGP-12177 provided a  antit tat ion of internalized BAR (see Fig.  5). 
Epidermal Growth Factor Binding--Intact 1321N1 cells were 
washed once with Hepes-Eagle's medium containing 0.1% bovine 
serum albumin and incubated with 4  ng/ml (lo5 cpmlml) EGF. The 
incubation was either performed at 37 "C for up to 120 min or, to 
determine a single cycle of internalization, cells were incubated with 
'=I-EGF for 2 h at 4 "C, washed, and  then incubated at 37 "C with 
nonlabeled EGF  in  the same buffer. After incubation at 37 "C, cells 
were chilled and washed five times  with assay buffer. To determine 
total binding, cells were solubilized in 0.1 N NaOH, and cell-associated 
radioactivity was determined in a y-counter. To determine internal- 
ized EGF, cells were washed for 5 min with 40 mM sodium acetate, 
pH 4.5, to remove cell-surface-bound EGF  and solubilized afknvards. 
To separate internalized EGF from plasma membrane EGF on a 
sucrose step gradient, cells were lysed by hypotonic shock after 
washing them. When cells had been treated with sodium acetate, they 
were washed afterwards thoroughly with assay buffer to readjust to 
pH 7.4 before lysis. Centrifugation was as described above for BAR. 
Determination of the Intracellular ATP Concentration-Cells  were 
s o ~ u b ~ ~ z e d  by addition of  1.5 ml of 70 "C 0.14 N HNO, to each dish. 
Dishes were incubated for an additional 20 min at 37 "C to allow 
complete solubilization. The supernatant was collected and centri- 
fuged for 10 min at 4000 X g. The  pH of the s u ~ r n a t ~ t  was adjusted 
to 7.0  by adding 0.6 N NaOH in 20  mM Tris. 
ATP content was determined using a bioluminescence assay. Light 
emission was detected with a Beckman scintillation counter using a 
single photomultiplier. 50 pl of the CLS reagent was diluted in 3.5 ml 
of reaction buffer (20 mM Hepes, 10 mM MgC12, 2 m M  EDTA, 0.18 
mM DTT,  and 0.15 mM AMP, pH 7.0). Samples (100 p1) were added 
to 1 ml  of this reaction mixture and light emission was measured for 
1 min. The signal was constant for at least 5 min due to  the  in~bition 
of the initial  rate by excess AMP. Under these conditions, a range of 
5 (IO5 cpm)-40  pmol (lo6 cpm) of ATP could  be determined. ATP 
content is expressed as nmol/lo6 cells. 
Determination of Adenylate Cyclase Activity-Adenylate cyclase 
activity was determined in cell lysates by the method of Salomon et 
ai. (21), which involves the separation of [32P]cAMP from r3'P]ATP 
on sequential columns of  Dowex 50 and Alumina. 
RESULTS 
Incubation of 1321N1  cells with 1251-EGF at  4 "C leads to 
selective binding to cell surface receptors (22). When such 
labeled  cells are washed and  the incubation is continued at 
37 "C, in the presence or absence of labeled EGF, a rapid 
translocation of Iz5I-EGF occurs  from sites on the cell  surface 
to sites within the cell  (15). This tr~slocation, which  presum- 
A 
5.1 
time, m in 
RG. 1. ~ t e r n ~ a t i o n  of epidermal growth factor. Cells 
were incubated with 4 ng/ml(105 cpm/ml) of lBI-EGF for 2 h at 4 "C. 
The medium  was changed, nonlabeled EGF  (4 ng/ml) was added in 
Hepes-Eagle's  medium supplemented with 0.1% bovine serum albu- 
min (37 "C), and cells were incubated for the time indicated. A, cells 
were washed and lysed, and plasma membrane (0) was separated 
from the vesicular fraction (0) on a sucrose step gradient. B, cells 
were incubated with sodium acetate, pH 4.5, to remove cell-surface- 
bound EGF, washed, lysed, and separated on a sucrose step gradient. 
ably occurs by receptor-mediated  endocytosis, can be followed 
in either of two ways. Upon incubation at 37 "C of cells 
prelabeled at 4 "C with  IZ5I-EGF, the label  rapidly moves from 
sites where the label is dissociated  by  acidic conditions (pre- 
sumably cell surface sites) to sites where it is not dissociated 
(15). We also have found that,  conco~itantly, acid-stabile 
1251-EGF appears in low density fractions of  cell lysates upon 
centrifugation over  sucrose gradients; whereas all acid-labile 
'%EGF is  associated  with  higher d nsity fractions. The effect 
of PA0 on this translocation has been investigated by com- 
bining both techniques. The  centr~ugation procedure was 
modified' to substitute a step gradient for a continuous gra- 
dient of sucrose, the internalized (acid-stabile) lz5I-EGF is 
collected at  a  15/38% interface, while the cell surface  (acid- 
labile)  label  accumulates at a 38/60% interface. Fig. 1 shows 
the time course of translocation of previously  bound (4 "C) 
'251-EGF during a  subsequent 37 "C incubation. Clearly, EGF 
bound at 4 "C is almost exclusively  associated with the plasma 
membrane fraction (Fig. lA), but rapidly moves into the low 
density fraction with time at  37 "C. 
In a related experiment, the cells were  washed at low pH to 
remove  membrane-bound lZ5I-EGF prior to lysis and centrif- 
ugation  over  sucrose gradients. The results (Fig. 1B) indicate 
that very little acid-stable l2'1-EGF is present immediately 
after binding at 4 "C. When the incuba~on was continued at  
37 "C, acid-stable lz51-EGF first appeared in association  with 
the heavy fractions and shortly thereafter in  the light frac- 
tions of the gradient. 
In Fig. 2 the effect of PA0 on  binding and internalization 
of 'T-EGF is ~ u s t r a ~ .  The protocol used is somewhat 
J. Kurz, unpubl~shed results. 
Inhibition of Receptor  Endocytosis by Phenylarsine Oxide 12549 
1 0 
03' 
cQtyod)-rro - o - o " o  -0 
8 I 
0 20 40 60 
time, min 
FIG. 2. Effect of PA0 on EGF internalization. Upper panel, 
cells were preincubated for 5 min with 100 p~ PAO. EGF (4 ng/ml, 
IO5 cpm/ml) was added to  the medium, the cells were incubated at  
37 "C for the  time indicated, washed; and lysed, and plasma mem- 
brane (0) was separated  from cytosolic vesicles (0) on a sucrose step 
gradient. Lower panel, cells were incubated with 4 ng/ml (10' cpm/ 
ml) of IZ5I-EGF for 2 h at  4 "C. Medium was changed and 4 ng/ml 
EGF plus 100 p~ PA0 were added. The incubation was carried out 
at 37 "C for the time indicated. Cells were washed, incubated at  pH 
4.5, washed, lysed and plasma membrane (0) was separated from 
cytosolic vesicles (0) on a sucrose step gradient. 
different than  that described  above for Fig. 1; namely,  cells 
were  exposed to lZ5I-EGF at 37 "C and  the appearance of label 
in light (internalized) and heavy (cell surface) fractions of 
sucrose gradients was  measured. Pretreatment of the cells  for 
5 min at 37 "C with 100 pM PA0 (IDso = 30 phi) completely 
inhibited appearance of '=I-EGF in the light fraction, whereas 
binding of lZ51-EGF to  the cell  surface appeared unaffected. 
Not only was no translocation of cell surface EGF to inter- 
nalized EGF detected, but incubation of labeled  cells at low 
pH prior to lysis  revealed that PA0 also prevents the forma- 
tion of acid-stable 1251-EGF associated  with the heavy frac- 
tions of the gradient (Fig. 2, lower panel, and compare Fig. 
1B). The difference in  the scales of the y axes of Fig.  2, upper 
and lower panels, should be noted. 
In  the following experiments, cells were preincubated at 
37 "C for 5 min  with PA0 at a concentration of 100 PM. These 
conditions result in complete inhibition of receptor-mediated 
endocytosis  even after extensive  washing of the cells post- 
exposure. This is operationally important since, under the 
exposure conditions chosen, the complicating  secondary  ac- 
tions of PA0 are readily  reversed by washing as discussed 
below. 
P A 0  had been  used  by others to inhibit internalization of 
EGF (15) and  other polypeptides (13, 14). PA0 is a trivalent 
arsenical and as such can form  readily  reversible  bonds with 
single sulfhydryl groups, or quite stable ring structures upon 
reaction with vicinal sulfhydryl  groups such as those in lipoic 
acid  (23). In  an attempt to characterize the chemical basis of 
inhibition of EGF endocytosis by  PAO, the effects ofa number 
TABLE I 
Reversibility of the inhibition by PA0 of internalization of EGF 
Cells were pretreated for 5 min with PA0 or 0.1% dimethyl 
sulfoxide in Hepes-Eagle's medium supplemented with 0.1% bovine 
serum albumin. 4 ng/ml (10' cpm/ml) of lZ5I-EGF was added and  the 
cells were incubated either for 2 h at  4 "C or for 30 min at 37 "C. The 
cells were transferred  on ice, washed, lysed, and layered on top of a 
sucrose step gradient. The 15/38% sucrose interface was collected 
and filtered. and radioactivitv was determined. 
~~ ~ 
Pretreatment '*'IIp-EGF 
cpmllow density fraction 
Control 
37 "C 5647 
100 p M  PA0 196 
100 p~ PAO, 1 mM glutathione 336 
100 pM PAO, 1 mM mercaptoethanol 201 
100 p~ PAO, 1 mM DTT 4179 
100 p~ PAO, 1 mM BAL 4306 
4 *e 198 
B 
0 20 60 
time, min 
FIG. 3. ReversibW,y of the  inhibition by P A 0  of EGF inter- 
nalization. Cells were preincubated with (0) or without (0) 100 p~ 
PA0 for 5 min at 37 "C. Then 4 ng/ml (lo5 cpm/ml) of '=I-EGF was 
added, and cells were incubated at  37 "C. At t = 10 min, either 1 mM 
DTT (0) or 1 mM BAL (A) was added. Cells were chilled at  the time 
indicated, washed, and lysed, and vesicles (A) were separated from 
plasma membrane ( B )  by a sucrose step gradient. 
of sulfhydryl compounds were tested for their capacity to 
prevent or reverse its effects. The protocol  was to incubate 
1321N1 cells  for 5 min at 37 "C with PA0 plus or minus a 
sulfhydryl  compound, then lZ5I-EGF was  added for an addi- 
tional 30 min and internalization was measured as the in- 
crease in radioactivity in the light fraction of sucrose gra- 
dients. Monofunctional sulfhydryl compounds (glutathione, 
2-mercaptoethanol) did not prevent the inhibitory action of 
PA0 while bifunctional reagents (DTT and BAL) prevented 
the inhibition almost completely (Table I).  The results in Fig. 
3 demonstrate that not only can DTT and BAL prevent the 
action of PA0 but they also  reverse the inhibition. Addition 
of 10 X molar  excess of DTT or BAL caused an immediate 
increase in internalized lZ5I-EGF and a complementary  de- 
cline in '=I-EGF  associated with the cell  surface. 
Since PA0 reacts with  sulfhydryl  groups and since other 
sulfhydryl-reactive  compounds inhibit mitochondrial function 
and/or glycolysis, it was  possible that  the inhibitory effects 
of PA0 on endocytosis were caused by  lowering  cellular ATP. 
We3 and others (10, 24-27), have shown that agents that 
lower ATP levels inhibit receptor-mediated  endocytosis. How- 
C. Hertel, S. J. Coulter, and J. P. Perkins,  manuscript  submitted 
for publication. 
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ever,  based ob  the results shown in Fig. 4, this mechanism 
seems not to offer a viable explanation for the actions of 
PAO. PA0 has no effect on ATP levels in 1321N1  cells under 
conditions (Fig.  4B)  where it completely prevents internali- 
zation of  ’251-EGF (or BAR, see  below). Treatment of cells in 
a nutrient-depleted medium  with PA0 caused  a  modest de- 
cline in ATP levels, but  this was prevented by the monofunc- 
tional sulfhydryl  compound glutathione (Fig. 4A) which  does 
not prevent the inhibition of endocytosis by PA0 (Table I}. 
One of the purposes of this study was to extend our com- 
parison of the mechanisms subserving ligand-induced BAR 
internalization and receptor-mediated EGF internalization. 
To  this end, the effects of PA0 on BAR internalization have 
been determined. Numerous  previous experiments (1-4)  have 
been consistent with the idea that exposure of 1321N1  cells 
to isoproterenol results in the rapid translocation of cell 
surface BAR to a location within cytosolic vesicles. Such 
vesicles can be isolated in low density fractions of sucrose 
gradients. In addition, the BAR in such vesicles appears to be 
inaccessible to hydrophilic ligands such as CGP-12177 (4,28). 
These two properties have  been  used to  quantitate ndocytosis 
of  BAR. Thus, we have  measured the appearance of  BAR in 
low density fractions of cell lysates after centrifugation over 
sucrose gradients, or we have  measured  changes in the appar- 
ent affinity of the hydrophilic  ligand  CGP-12177 as a  com- 
petitor of  1251-CYP binding to cell  lysates. 
PA0 (100 PM) was  added to cells  5  min prior to a  20-min 
incubation with 1 p~ isoproterenol. Complete inhibition of 
the formation of  BAR with low affinity for CGP-12177 or of 
f o ~ a t i o n  of the low density form of BAR was observed 
(compare Fig. 5).  The  apparent IDso for PA0 for a 5-min 
incubation at 37 “C was  30 y~ for inhibition of  BAR inter- 
nalization as well as for EGF internalization. As was the case 
for EGF internalization, bifunctional but not monofunctional 
sulfhydryl  compounds inhibited or reversed the effect of PA0 
on BAR internalization (Table 11). 
Initially our experiments with BAR were complicated by 
an effect of PA0 on BAR function per se; that  is  to say, 
a n t ~ o n i s t  binding was reduced in agonist-pretrea~ cells 
(Table 11). However, this effect of PA0 was found to be 
reversed by extensive washing of the cells after the  standard 
5-min  exposure to PAO. Such washing (5  x 10 ml  over 5 min) 
did not reverse inhibition of  BAR internalization. Also, ad- 
I I 7 
A I  
time, min 
F’IG. 4. Effect  of PA0 on intracellular ATP  concentration. 
A, cells were incubated in nutrient-depleted growth medium (0) and 
either 100 p~ PA0 (X) or PA0  and 1 mM glutathione (O), or PA0 
and 1 mM DTT (0) was added. At the times indicated, cells were 
chilled and  ATP was extracted. B, cells were incubated in nutrient 
containing Hepes Eagle’s medium (0) and either 100 pM PA0 (X) or 




FIG. 5. Reversible  effect  of PA0 on internalization  of BAR. 
Internalization of  BAR was determined either as appearance of low 
affinity for CGP-12177 in lysates (left side) or as appearance of 
vesicular BAR on a sucrose step gradient (right side). Receptor 
distribution without pretreatment is shown in pnnel A for control (0, 
111 ) and desensitized (20 min with 1 FM isoproterenol) cells (0, z). 
CyanopindoIol binding is given as per cent of binding in the absence 
of CGP-12177. BAR in  the vesicular fraction was determined by the 
extent of binding in the presence of 50 pM lwI-CYP. Panel €3 shows 
the  dist~bution of the receptors after pretreatment with 100 pM PA0 
and 1 mM glutathione for 5 min. Panel shows the distribution of 
the receptor after  pretreatment with 100 pM PA0  and 1 mM DTT. 
dition of glutathione or mercaptoethanol simultaneously  with 
PA0 prevented loss of antagonist binding, but had no effect 
on the inhibition by PA0 of  BAR internalization. 
The KO and Bmx values  for 1251-CYP binding were deter- 
mined by Scatchard plot analysis after pretreatment of 
1321N1 cells under various conditions (Table 111). PA0 alone 
had no detectable effect on either KB or B,, for 1251-CYP. 
However, treatment of cells with PA0 in the presence of 
isoproterenol  resulted in a  35%  decrease in the Bmx and a 
35% increase in KO (Table 111). Washing the cells before 
adding  isoproterenol, or including glutathione in the mixture, 
prevented both effects. 
The effect of PA0 on BAR binding properties also was 
determined by directly exposing  cell lysates to PAO. Neither 
the KD nor the Bmax for 12sI-CYP  were altered by the presence 
of P A 0  (100 PM) in a standard binding  assay  (Fig. 6). How- 
ever, PA0 had a  marked  effect on the apparent affinity of 
BAR for the agonist isopro~renol (Fig. 7). The typical  shallow 
or biphasic  competition  curve for isoproterenol in the absence 
of GTP (29) was observed in lysates  from control cells. PA0 
caused a significant increase in the apparent affinity for 
isoproterenol. The inclusion of either GTP (500 PM) or glu- 
tathione (1 mM) prevented or reversed this effect of PAO; 
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TABLE I1 
Inhibition of formation of low affinity for CGP-12177 
Cells were pretreated for 5 min at 37 "C with 100 pM PAO. 1 pM 
isoproterenol together with the thiol reagents was added for an 
additional 20 min. Cells were lysed and binding of 10 pM '251-CYP 
was determined in the presence or absence of 10 nM CGP-12177. 
Nonspecific binding was determined in  the presence of 1 p M  propran- 
olol. The right column shows specific binding of lBI-CYP. This value 
was defined as 100%. The left column shows binding of '2sI-CYP in 
the presence of CGP-12177. This is expressed as per  cent of binding 
in  the absence of CGP-12177 (right column). LOW percentage lZ5I- 
CYP binding is  therefore due to high accessibility for CGP-12177, 






Control 7 7.6 
1 p~ isoproterenol 41  6.8
1 p~ isoproterenol + 100 p~ PA0 12 3.5 
Isoproterenol + PA0 + 1 mM glutathione 11 6.3 
Isoproterenol + PA0 + 1 mM mercaptoethanol 10 6.8 
Isoproterenol + PA0 1 mM cysteine 13 3.7 
Isoproterenol + PA0 + 1 mM DTT 36  6.3
Isoproterenol + PA0 + 1 mM BAL 37  6.1
PAO, wash, isoproterenol 14 5.4 
Isoproterenol + PA0 after 10 min:BAL 32  6.6
Isoproterenol + PA0 after 10 min:DTT 42  6.3
TABLE I11 
Effect of PAOpretreatment on antagonist binding 
Cells were pretreated for 5 min with PAO, followed  by a 20-min 
incubation with or without isoproterenol. In line 6, cells were washed 
extensively before isoproterenol was added. In  the experiment de- 
scribed in line 7, l mM glutathione was added together with isopro- 
terenol. Cells were washed and lysed and B,, and KD for '251-CYP 
were determined in a saturation binding experiment according to 
Scatchard (33). 
Pretreatment B,, KO 
fmollmg protein p~ 
0.1% dimethyl sulfoxide 11.3  6.9 
0.1% dimethyl sulfoxide, 1 p~ iso- 10.2  6.9 
100 p M  PA0 
proterenol 
11.9  7.5 
100 pM PAO, 1 pM isoproterenol 7.4  10.9 
100 PM PAO, wash 12.5  7.3 
100 pM PAO, wash, isoproterenol 11.7  6.6
100 pM PAO, 1 mM glutathione, 1 11.6  9.6 
p~ isoproterenol 
DTT caused a marked further decline in  the affinity of BAR 
for isoproterenol. These  results are similar to those of Korner 
et al. (30) and Vauquelin et al. (31), who studied the effects of 
N-ethylmaleimide. It can be suggested that like N-ethylmal- 
eimide, PA0 stabilizes an agonist-BAR-N. (stimulating GTP- 
binding  protein of adenylate cyclase) protein  ternary complex 
to account for the increase in agonist affinity. 
The effect of PA0 on an additional aspect of agonist- 
induced modification of BAR function, the responsiveness of 
adenylate cyclase to isoproterenol, has been examined (Table 
IV). Responsiveness of lysates from control cells (not  treated 
with either isoproterenol or PAO) is expressed as  the ratio of 
enzyme activity in  the presence of isoproterenol to activity in 
its absence; the numerical value 12.5 indicates the magnitude 
of stimulation of basal  activity by the BAR agonist. When 
cells were treated with isoproterenol for 20 min, then  thor- 
oughly washed and  the cell lysate exposed to 10 p~ isoproter- 
enol, the magnitude of stimulation was found to have been 
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FIG. 6. Binding of cyanopindolol in the presence of PAO. 
Binding of 1251-CYP to cell lysates was determined in the presence 
(0) or absence (0) of 100 p~ PAO. Data were analyzed according to 
Scatchard (33). 
tion. The activity of adenylate cyclase in  the presence of 1 
mM NaF was the same (ratios of 9.3 and 10.5) in both 
instances, confirming the selective nature of the desensitiza- 
tion. The effect of PA0 on desensitization was determined by 
interposing a 5-min preincubation of the cells with 100 PM 
PA0 and 1.0 mM glutathione. This condition completely 
blocks BAR or EGF  internalization (see above). The subse- 
quent 20-min exposure to isoproterenol resulted in a 35% 
desensitization. Again enzyme activity in  the presence of NaF 
was found to be unaltered. PA0 caused a modest decrease in 
basal activity (1.5 to 1.2 pmol/min/mg of protein) and a 
modest increase in  NaF activity (14.0 to 17.4 pmol/min/mg 
of protein). Basal activity was decreased by  more than 50% 
in the presence of DTT or BAL (Table IV). As might be 
expected, desensitization occurred normally after pretreat- 
ment of cells with PA0 plus  a bifunctional sulfhydryl agent 
(DTT, BAL). 
DISCUSSION 
Previous investigators have reported that PA0 inhibits 
internalization of protein into oocytes (12) and receptor- 
mediated endocytosis of protein nexin (14), EGF (15), and 
insulin (13). However, the mechanism of action of this  triva- 
lent arsenical was not explored. Early  studies (23) established 
that trivalent arsenicals form stabile ring structures with 
molecules having appropriately spaced vicinal sulfhydryl 
groups. Five-membered rings appear to be most stabile. The 
equilibrium of such a reaction strongly favors the complex, 
and monofunctional sulfhydryl agents are not effective in 
competing in such a reaction (23). Thus, the results of our 
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FIG. 7. Effect of PA0 on agonist 
binding. Competition binding of 
CYP  and  isoproterenol  was  performed in 
lysates in the  presence of either 100 p~ 
PA0 (X), PA0 and 1 mM glutathione 
(A), PA0 and 1 mM DTT (a), PA0 and 
500 p~ GTP (0), or  with 0.1% dimethyl 
sulfoxide (0). Cyanopindolol binding is 
shown as per  cent of binding in  the  ab- 
sence of isoproterenol. 
-Iog[isoproterenoIl 
TABLE IV
Adeny~a~~ cyclase activity 
Adenylate cyclase activity was determined in lysabs from cells 
pretreated  for 5 min under  the  conditions  indicated,  with or without 
an  additional  incubation  for 20 min  with 1 p M  isoproterenol.  Mean 
values f S.E. ace  given.  Basal activities were:  control 1 3  f 0.2, PA0 
1.2 f 0.1, P A 0  + glutathione 1.1 f 0.2, PA0 +- DTT 0.5 f 0.2, PA0 
+ dimercaptopropanolO.6 f 0.2 pmol/min/mg of protein. 





10 g M  iso- 10 mM NaF 
- f d  
0.1% dimethyl  sulfoxide" 
Control 











100 p~ PAO, 1 mM glu- 
100 p~ PAO, 1 mM DT?" 
100 p~ PAO, 1 mM BAL" 
12.5 rt 1.6 
8.9 & 1.3 
5.8 f 1.4 
3.6 & 0.3 
14.0 f 2.6 
9.1 f 1.2 
20.3 f 4.0 
13.9 f 1.9 
27.2 f 2.8 
17.0 2 2.7 
9.3 f 1.8 
10.5 f 2.1 
14.5 f 1.0 
12.3 f 0.7 
9.5 f 1.1 
8.5 f 3.2 
16.4 zk 3.0 
16.5 f 2.8 
17.9 f 2.0 




studies tentatively point to  the involvement of vicinal  sulfhy- 
dryl groups in the inhibitory action of PA0 on receptor- 
mediated  endocytosis. 
Wiley and ~ ~ ~ n g h ~  (15) stated that  PA0 caused an 
irreversible inhibition of EGF internalization in cultured hu- 
man fibroblasts. It is a consistent finding that extensive 
washing of PAO-treated cells  does not reinstate endocytosis. 
Irreversible inhibition could result from  nonspecific interac- 
tions and in such a  case PA0 would  be a  less  useful  tool in 
the elucidation of the molecular  mechanism of endocytosis. 
For example, trivalent arsenicals are known to interact with 
a  large variety of enzymes  including those involved in ATP 
generation. Thus, irreversible inhibition of ATP production 
could  lead to general debilitation of cell integrity and a loss 
in  the capacity to mount a  complex event like  endocytosis. 
Others have cautioned against the use of PAO-treated cells 
after 3 4  h (13). 
Our studies provide  two  useful,  probably  generally appli- 
cable items of information. First, the effects of PA0 on. 
endocytosis can be prevented and, more importantly, reversed 
by bifunctional sulfhydryl  compounds.  Second, PA0 inhibits 
endocytosis under con~tions where  cellular ATP levels are 
not changed. The stability of the ~ ~ b i t e d  state and its 
reversal by bifunetional, but not monofunctional,  sulfhydryl 
agents suggests a somewhat  selective interaction with a  bio- 
logical  molecule containing vicinal  sulfhydryl  groups. 
One purpose of our studies was to examine further the 
similarities in  the endocytosis of  BAR and EGF. Preliminary 
work from  our laboratory had shown that  the time courses of 
internalization of  BAR and EGF were similar (but not iden- 
tical): both processes were  blocked  by  reduced temperature, 
both were  blocked  by treatment of cells  with concanav~in A 
(22), and both were  blocked  by  a reduction in cellular ATP3 
(although not  to  the same extent). The present study dem- 
onstrates that endocytosis of both BAR and EGF are inhibited 
in similar fashion by PAO. Furthermore, it is demonstrated 
that PA0 blocks the appearance of acid-stabile lZ5I-EGF in a 
plasma  membrane fraction, suggesting that  this form of the 
EGF-receptor complex is a  consequence of endocytosis. The 
time course of its appearance (about 5 min earlier than in the 
low density fraction) suggests further that it occurs at  an 
early step during e n d o c ~ s i s .  A  possibly related observation 
was  recently  made with BAR (3). In this case, isopro~renol 
induced  a  form of the BAR that was  inaccessible to hydro- 
philic ligands, but that co-migrated  with the heavy fraction 
on sucrose gradients. A  possible explanation for both of these 
observations is the formation of invaginated segments of the 
plasma  membrane that were yet to form as completed endo- 
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somes, as  has been described in  other systems (32). 
Since PA0 had secondary effects on BAR, it was necessary 
to develop conditions  to separate  its actions  on BAR proper- 
tiesper se and effects on endocytosis. Fortunately, the former 
effects of PA0 were completely prevented by glutathione or 
2-mercaptoethanol. When these secondary effects of PA0 
were prevented,  internalization of BAR remained inhibited; 
however, uncoupling between BAR and adenylate cyclase still 
occurred. Therefore, consistent with previous observations 
(19) it is possible to distinguish  reactions leading to uncou- 
pling and  those leading to receptor internalization. It follows 
that 1321N1 cells possess a mechanism for uncoupling the 
cellular response to  the ligand even when receptor internali- 
zation is prevented. 
Ligand-induced endocytosis of BAR occurs in 1321N1 cells 
by a process we have yet to be able to distinguish from 
receptor-mediated endocytosis of EGF. However, our results 
only address similarities in the early steps of the overall 
process; thus, we cannot comment on possible similarities in 
steps subsequent to internalization such as recycling of recep- 
tor or ligand to the cell surface, or degradative pathways for 
receptor or ligand. However, to the  extent  that subsequent 
steps  in the pathways  can be shown to be similar,  studies of 
BAR processing may be generally enlightening of the mech- 
anism of endocytosis, since, of the common receptors studied 
in this area, only the BAR can be measured directly after 
internalization has occurred. The availability of a number of 
high affinity, highly selective, membrane-permeable radioli- 
gands for this receptor provides unique tools with which to 
follow the dynamics of receptor internalization and process- 
ing. 
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